These findings reveal new targets for the therapy of HCC by regulatory connections between miR-139-5p and transcription factor (ETS1) that regulate aerobic glycolysis, proliferation, and metastasis in HCC cells (77–79). Here, ETS1 is linked to hepatocellular carcinoma.